文献速递肿瘤 PET/CT神经核医学

18F-MFBG PET/CT与18F-FDG PET/CT在转移性神经母细胞瘤图像中的比较

Comparison of 18 F-MFBG PET/CT and 18 F-FDG PET/CT Images of Metastatic Neuroblastoma.
PubMed 文献 · Clin Nucl Med · 2024-04-06

两名神经母细胞瘤患儿在肿瘤切除及术后化疗后参加临床试验,接受18F-MFBG与18F-FDG PET/CT检查。两次检查发现相似病灶但摄取模式不同:淋巴结和骨病灶18F-MFBG活性强而18F-FDG摄取不明显,骨髓18F-MFBG摄取显著强于18F-FDG。本文强调18F-MFBG PET/CT在检测神经母细胞瘤转移方面优于18F-FDG PET/CT。

要点

  • 淋巴结和骨病灶18F-MFBG活性强,而18F-FDG摄取不明显。
  • 骨髓18F-MFBG摄取显著强于18F-FDG。
  • 本文强调18F-MFBG PET/CT检测神经母细胞瘤转移优于18F-FDG PET/CT。

核心结论

  • 本文强调18F-MFBG PET/CT在检测神经母细胞瘤转移方面优于18F-FDG PET/CT。

研究设计与样本

  • 两名神经母细胞瘤患儿在肿瘤切除及术后化疗后参加临床试验,接受18F-MFBG与18F-FDG PET/CT检查。

主要发现

  • 两次检查发现相似病灶,但摄取模式不同。
  • 淋巴结和骨病灶18F-MFBG活性强,而18F-FDG摄取不明显。
  • 骨髓18F-MFBG摄取显著强于18F-FDG。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Two children with neuroblastoma underwent tumor resection and postoperative chemotherapy. After treatment, they participated in a clinical trial and received 18 F-MFBG and 18 F-FDG PET/CT examinations. Although similar lesions were found in the 2 examinations, the uptake pattern was different. The lymph nodes and bone lesions had intense 18 F-MFBG activity, whereas 18 F-FDG uptake was not very impressive. The uptake of bone marrow by 18 F-MFBG was significantly stronger than that by 18 F-FDG. This case emphasizes that 18 F-MFBG PET/CT is superior to 18 F-FDG PET/CT in detecting the metastases of neuroblastoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zhang W, Liu L, Yuan G, et al. Comparison of 18 F-MFBG PET/CT and 18 F-FDG PET/CT Images of Metastatic Neuroblastoma. Clin Nucl Med. 2024. PMID: 38598743. doi:10.1097/RLU.0000000000005226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。